A new second-line therapy for Primary Biliary Cholangitis: Elafibranor

Can seladelpar serve as second-line treatment for PBC patients with inadequate UDCA therapy?

October 27, 2025

SCOPE Index

October 23, 2022

Do Steroids Improve Outcomes After Kasai Hepatoportoenterostomy

September 13, 2022